The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Stock and Other Ownership Interests - Perthera
Consulting or Advisory Role - Celgene; Perthera; Sirtex Medical
Speakers' Bureau - Celgene; Sirtex Medical
Travel, Accommodations, Expenses - Celgene; Perthera; Sirtex Medical
Phase 1 dose escalation study of MEDI-565, a bispecific T-cell engager that targets human carcinoembryonic antigen (CEA), in patients with advanced gastrointestinal (GI) adenocarcinomas.
 
Michael J. Pishvaian
No Relationships to Disclose
 
Michael Morse
Stock and Other Ownership Interests - PhytoChem
Honoraria - Astellas Pharma; Bayer; Etubics; Genentech/Roche; Ipsen; Lexicon; Novartis; Onyx; Regeneron; Sanofi; Taiho Pharmaceutical
Speakers' Bureau - Celgene; Genentech/Roche; Novartis
Research Funding - Advanced Accelerator Applications (Inst); AlphaVax (Inst); Bristol-Myers Squibb (Inst); Eisai (Inst); Lexicon (Inst); MedImmune (Inst); Onyx (Inst); Precision Biologics (Inst)
 
Jennifer T. McDevitt
Employment - MedImmune
Stock and Other Ownership Interests - MedImmune
 
Song Ren
Employment - MedImmune
Stock and Other Ownership Interests - AstraZeneca
 
Gabriel Robbie
Employment - MedImmune
Research Funding - MedImmune
 
Patricia C. Ryan
Employment - MedImmune
Research Funding - AstraZeneca/MedImmune (Inst)
Other Relationship - AstraZeneca/MedImmune
 
Serguei Soukharev
Employment - MedImmune
Stock and Other Ownership Interests - MedImmune
 
Haifeng Bao
Employment - MedImmune
Stock and Other Ownership Interests - MedImmune
 
Crystal Shereen Denlinger
Consulting or Advisory Role - Lilly; Merrimack
Research Funding - Astex Pharmaceuticals (Inst); Bayer (Inst); Genentech (Inst); Lilly/ImClone (Inst); MedImmune (Inst); Merrimack (Inst); OncoCyte (Inst); OncoMed (Inst); Pfizer (Inst)